Persistent Pulmonary Hypertension of the Newborn
📧 Sign up to get email alerts when something new happens for Persistent Pulmonary Hypertension of the Newborn.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: Pharmacokinetic Study of Milrinone in Babies With Persistent Pulmonary Hypertension of the Newborn [NA]
This clinical trial update reports on a pharmacokinetic study of milrinone in newborns with persistent pulmonary hypertension of the newborn…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: N-Terminal Pro-brain Natriuretic Peptide Hormone and Persistent Pulmonary Hypertension
A clinical trial investigating N-terminal pro-brain natriuretic peptide (NT-proBNP) in persistent pulmonary hypertension of the newborn has …
-
FDA label_change · 2016-04-05FDA Approved: INOMAX — Supplemental Application (INO Therapeutics LLC)
FDA approved a supplemental application for INOMAX (nitric oxide) from INO Therapeutics LLC to update its labeling.
-
CLINICAL_TRIALS research · 2016-02-18Clinical Trial Update: Epidemiology of Persistent Pulmonary Hypertension of the Newborn - SCOR in Lung Biology and Diseases in Infants and Children
A completed epidemiological study on Persistent Pulmonary Hypertension of the Newborn (PPHN) under NHLBI's SCOR program in Lung Biology and …
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Persistent Pulmonary Hypertension of the Newborn [Phase 3]
A Phase 3 clinical trial for Persistent Pulmonary Hypertension of the Newborn was terminated, with results posted in 2015.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-01-19Clinical Trial Update: Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients [Phase 1, Phase 2]
A pediatric phase 1/2 trial evaluating inhaled iloprost as an adjunct to inhaled nitric oxide for pulmonary hypertension and related neonata…
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants. [Phase 4]
Phase 4 clinical trial evaluating inhaled iloprost for persistent pulmonary hypertension in term and near-term infants has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-05-29Clinical Trial Update: NO Need to Ventilate: A Trial of Non-invasive Inhaled Nitric Oxide in Persistent Pulmonary Hypertension of the Newborn [NA]
A completed clinical trial evaluating inhaled nitric oxide as non-invasive therapy for persistent pulmonary hypertension of the newborn.
-
FDA approval · 2014-02-28FDA Approved: INOMAX — Supplemental Application (INO Therapeutics LLC)
The FDA approved a supplemental application for INOMAX (nitric oxide) from INO Therapeutics LLC, updating the product's labeling and/or indi…
-
FDA approval · 2013-03-04FDA Approved: INOMAX — Supplemental Application (INO Therapeutics LLC)
The FDA approved a supplemental application for INOMAX (nitric oxide) from INO Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN) [Phase 2]
A Phase 2 trial assessing sildenafil for safety and efficacy in newborns with persistent pulmonary hypertension (PPHN) has been terminated w…
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Sildenofil in Persistent Pulmonary Hypertension in Newborns [Phase 3]
A Phase 3 clinical trial evaluating sildenafil for persistent pulmonary hypertension of the newborn is ongoing, sponsored by Hamad Medical C…
-
CLINICAL_TRIALS research · 2011-06-15Clinical Trial Update: Nitro Oxide Inhalation Continued With Sildenafil on Neonatal Persistent Pulmonary Hypertension [NA]
A clinical trial evaluating inhaled nitric oxide in combination with sildenafil for Persistent Pulmonary Hypertension of the Newborn; the cu…
-
FDA approval · 2009-08-26FDA Approved: INOMAX — Supplemental Application (INO Therapeutics LLC)
FDA approved a supplemental application for INOMAX (nitric oxide) from INO Therapeutics LLC. The approval updates the existing NDA for INOMA…
-
CLINICAL_TRIALS withdrawal · 2009-02-04Clinical Trial Update: Treatment of Elevated Arterial Pulmonary Pressure With Inhaled Iloprost [NA]
A clinical trial evaluating inhaled iloprost for elevated arterial pulmonary pressure has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2008-08-12Clinical Trial Update: Inhaled Nitric Oxide by Oxygen Hood in Neonates [Phase 4]
Phase 4 clinical trial evaluating inhaled nitric oxide delivered by an oxygen hood in neonates with respiratory failure, including persisten…
-
FDA approval · 2007-12-04FDA Approved: INOMAX — Supplemental Application (INO Therapeutics LLC)
The FDA approved a supplemental application for INOMAX (nitric oxide) from INO Therapeutics LLC, resulting in updated labeling for this inha…